Conclusions
The global pandemic from COVID-19 represents one of the greatest health challenges in human history. Pending the discovery of an effective vaccine and antivirals directed against Sars-Cov-2, it is essential to recognize factors that may increase the risk of infection or worsen complications from COVID-19. The identification of effective preventive and therapeutic strategies is urgently needed especially for patients with chronic diseases such as diabetes. Patients with diabetes are at greater risk in this pandemic period, and even diabetes therapy can be complex to manage during a COVID-19 infection. Clinical data and EBM to be translated into guidelines by scientific societies and countries are needed to better guide clinicians in the complex management of a diabetes patient who is COVID-19 positive.